4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-19-000322
Director bought 20,000 shares at an average $1.26 ($25,288)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SAXE JON S Director | 2019-03-13 | Purchase | +12,080 | $1.26 | $15,201 | 12,080 | I |
| SAXE JON S Director | 2019-03-14 | Purchase | +7,920 | $1.27 | $10,086 | 20,000 | I |
| Open-market purchases · 20,000 sh · avg $1.26 · $25,288 | |||||||
Loading xslF345X03/form4-03142019_020358.xml…